General Nephrology

General Nephrology

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O; REPRISE Trial Investigators.
N Engl J Med. 2017 Nov 4
Google Plus
LinkedIn

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B; EMPA-REG OUTCOME Investigators
N Engl J Med. 2016 Jul 28;375(4):323-34. doi: 10.1056/NEJMoa1515920
Google Plus
LinkedIn

Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications

Hiddo J.L. Heerspink, Bruce A. Perkins, David H. Fitchett, Mansoor Husain, David Z. I. Cherney
Circulation. 2016 Sep 6;134(10):752-72
Google Plus
LinkedIn

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

Ayoub I, Hebert L Rovin BH
N Engl J Med. 2015 Dec 3;373(23):2225-36
Google Plus
LinkedIn

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis

Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quémeneur T, Blanchard-Delaunay C, Godmer P, Puéchal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, R
N Engl J Med. 2014 Nov 6;371(19):1771-80
Google Plus
LinkedIn

Efficacy of remission-induction regimens for ANCA-associated vasculitis

Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH; RAVE-ITN Research Group.
N Engl J Med. 2013 Aug 1;369(5):417-27
Google Plus
LinkedIn

IgA nephropathy

Wyatt RJ, Julian BA
N Engl J Med. 2013 Jun 20;368(25):2402-14
Google Plus
LinkedIn

Tolvaptan in patients with autosomal dominant polycystic kidney disease

Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators
N Engl J Med. 2012 Dec 20;367(25):2407-18
Google Plus
LinkedIn

Acute kidney injury

Bellomo R, Kellum JA, Ronco C
Lancet. 2012 Aug 25;380(9843):756-66
Google Plus
LinkedIn

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study (LUNAR)

Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J, Maciuca R, Zhang D, Garg JP, Brunetta P, Appel G; LUNAR Investigator Group
Arthritis Rheum. 2012 Apr;64(4):1215-26
Google Plus
LinkedIn

[12 3 4  >>  
Suggest an Article or Abstract

For suggested articles, Simply enter an article's PubMed ID number and our reviewers will consider the article for addition to the archive. Otherwise, attach a PDF below. You may also submit a visual abstract for consideration

Or
Add files